Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia

Published:2020-12-01 Issue:4 Volume:62 Page:899-908
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

West Zachary E.¹,Castellino Sharon M.¹²^ORCID,Monroe Caitlin²,Thomas Amanda S.³,McCracken Courtney³,Miller Tamara P.¹²^ORCID

Affiliation:

1. Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

2. Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA, USA

3. Department of Pediatrics, Biostatistics Core, Emory University School of Medicine, Atlanta, GA, USA

Funder

National Institutes of Health/National Cancer Institute

Aflac Cancer and Blood Disorders Center

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1852471

Reference41 articles.

1. Acute Lymphoblastic Leukemia in Children

2. Treatment of Pediatric Acute Lymphoblastic Leukemia

3. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

4. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

5. Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Discharge Checklist and Improved Education Reduces Hospital Readmission Rates in Childhood Leukemia Patients Receiving Induction Therapy;Journal of Pediatric Hematology/Oncology;2024-07-04

2. An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia;Journal of Clinical Medicine;2024-03-20

3. Clinical Characteristics and Cytogenetics of Childhood Acute Lymphoblastic Leukemia in a Single Center in Pakistan;Global Pediatric Health;2024-01

4. Assessing Risk Classification in Medication-Induced Diabetes during Induction Therapy in Pediatric Acute Lymphoblastic Leukemia;Pediatric Diabetes;2023-12-16

5. Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment;Hematology;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3